Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Relaxing tendons and collaterals" (Shujin Huoluo) is a therapeutic concept and clinical indication rooted in Traditional Chinese Medicine (TCM) rather than a specific molecular target, receptor, or enzyme. It describes a pharmacological effect intended to alleviate musculoskeletal pain, reduce muscle stiffness, and improve microcirculation in the limbs and joints (WHO International Standard Terminologies on TCM). In modern drug discovery, this term is frequently used to describe the polypharmacological activity of herbal extracts or multi-component formulations that possess anti-inflammatory, analgesic, and antispasmodic properties. Because it represents a physiological outcome or a broad therapeutic principle involving multiple biological pathways—such as the inhibition of COX-2 or the regulation of calcium signaling in smooth muscle—it does not possess a unique UniProt ID or a discrete molecular structure. Consequently, it is categorized as a therapeutic category or indication rather than a valid biological target for drug development (PubMed: 30204306, NIH: NCCAM).
In Traditional Chinese Medicine (TCM), the mechanism involves restoring the flow of Qi and blood to the 'meridians' and 'collaterals' to alleviate stagnation. From a modern pharmacological perspective, this is achieved through the inhibition of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), reduction of oxidative stress in connective tissues, and modulation of neuromuscular junctions to promote muscle relaxation (PMC7345331, PMC6270830).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Relaxing tendons and collaterals.